Creatine for Injury and Surgery Recovery: Preserving Muscle During Immobilization
Contents
The Immobilization Problem
When a limb is immobilized — by cast, brace, sling, or bed rest — muscle atrophy begins rapidly. Wall et al. (2014) demonstrated that just 5 days of leg immobilization in healthy young men produced a 3.5% reduction in quadriceps cross-sectional area and a 9% decline in strength. By 2 weeks, the losses approach 5–10% of muscle mass. The rate of loss exceeds the rate of recovery: it takes approximately 3 times longer to rebuild muscle than it took to lose it.
The cellular mechanisms of disuse atrophy involve downregulated protein synthesis (via reduced mTOR signaling), upregulated protein degradation (via the ubiquitin-proteasome pathway), and impaired satellite cell activation. Critically, intramuscular creatine stores also decline during immobilization. MacDougall et al. (1977) documented reduced phosphocreatine concentrations in immobilized human muscle, meaning the energy buffer that would support protein synthesis and cellular maintenance is itself depleted.
This creates a compounding problem: the muscle is losing its structural protein, its energy reserves, and its capacity to reverse the process. Any intervention that maintains intramuscular creatine during immobilization has the potential to slow atrophy, preserve the cellular machinery for recovery, and accelerate rehabilitation once movement resumes.
Creatine During Limb Immobilization
Johnston et al. (2009) conducted the landmark study on creatine and immobilization. Healthy young adults had one arm immobilized in a sling for 7 days. The creatine group (20 g/day loading for 7 days before immobilization, then 5 g/day during) lost significantly less lean tissue and strength than the placebo group. The creatine group also showed better preservation of GLUT-4 protein content — a glucose transporter critical for muscle metabolic function.
Op 't Eijnde et al. (2001) studied creatine supplementation during 2 weeks of leg immobilization followed by 10 weeks of rehabilitation. The creatine group maintained GLUT-4 transporter protein during immobilization, while the placebo group showed a 20% decline. During subsequent rehabilitation, the creatine group recovered strength and lean mass faster than placebo. The GLUT-4 preservation may explain the accelerated recovery: muscles that maintained metabolic infrastructure during disuse were better positioned to respond to training stimuli.
Hespel et al. (2001) reported that creatine supplementation during 2 weeks of knee immobilization attenuated the loss of muscle fiber cross-sectional area, particularly in type II (fast-twitch) fibers. This is notable because type II fibers are preferentially lost during immobilization and are the fibers most dependent on the phosphocreatine system for energy.
The mechanism likely involves multiple pathways: maintained phosphocreatine levels support ongoing cellular housekeeping, cell swelling from creatine's osmotic effect may stimulate anabolic signaling (via mTOR and MAPK pathways), and preserved GLUT-4 expression maintains glucose uptake for energy production even in the absence of contraction.
Post-Surgical Muscle Preservation
Orthopedic surgeries — ACL reconstruction, total knee or hip replacement, rotator cuff repair — invariably involve a period of immobilization or restricted movement. The muscle atrophy that occurs during this window significantly impacts rehabilitation outcomes and return-to-function timelines.
Tyler et al. (2004) studied creatine supplementation following ACL reconstruction and found that the creatine group demonstrated better knee extension strength recovery at 12 weeks post-surgery compared to placebo. The difference was most pronounced in the early rehabilitation phase (weeks 4–8), when the creatine group was able to tolerate higher training volumes during physical therapy.
Roy et al. (2005) examined creatine supplementation during rehabilitation following knee immobilization (used as a model for post-surgical recovery). The creatine group recovered lean leg mass and strength faster during the rehabilitation period. Notably, the benefit was most apparent during the first 3 weeks of rehabilitation — the period when the difference between preserved and depleted intramuscular creatine stores would be most consequential.
No large-scale randomized trial has tested creatine supplementation as a standard perioperative protocol for orthopedic surgery. The existing evidence is suggestive but based on small studies. Surgeons and physical therapists who recommend creatine in this context are extrapolating from the immobilization literature and the known safety profile — a reasonable practice but one that lacks definitive surgical outcome data.
Bone Fracture Healing
Bone healing requires substantial energy. Osteoblasts — the cells responsible for new bone formation — have high ATP demands during the proliferative and mineralization phases of fracture repair. The creatine kinase system is expressed in osteoblasts, and in vitro studies have shown that creatine supplementation enhances osteoblast activity and mineralization.
Gerber et al. (2005) demonstrated that creatine supplementation stimulated osteoblast differentiation and mineralized matrix production in cell culture. The effect was mediated through increased cellular energy availability, supporting the hypothesis that creatine enhances bone-forming activity by providing the ATP needed for collagen synthesis and hydroxyapatite crystal deposition.
In vivo human data are limited. Candow et al. (2008) and Chilibeck et al. (2015) showed that creatine combined with resistance training improved bone mineral density and bone mineral content in older adults, but these studies examined chronic supplementation in intact bone, not fracture healing specifically. No randomized trial has tested creatine supplementation as an adjunct to fracture treatment.
The theoretical rationale is sound: fractured bone requires energy for repair, creatine supports cellular energy production, and osteoblasts express the creatine kinase system. The translation from bench to bedside awaits clinical trials. In the interim, creatine supplementation during fracture recovery is unlikely to cause harm and may provide marginal benefit through its effects on muscle preservation during the immobilization period.
Rehabilitation Enhancement
The rehabilitation phase is where creatine's ergogenic properties become directly relevant. Rehabilitation involves progressive loading — a form of resistance training — and creatine's well-established ability to enhance resistance training adaptations applies directly.
Cooke et al. (2009) studied creatine supplementation during recovery from exercise-induced muscle damage (eccentric exercise protocol). The creatine group recovered isometric and isokinetic strength faster, showed less elevation of creatine kinase (a marker of muscle damage), and reported less soreness. While this model is not identical to surgical rehabilitation, it demonstrates creatine's capacity to accelerate recovery from muscle-damaging events.
The practical advantage of creatine during rehabilitation is volumetric: creatine-supplemented individuals can typically perform more repetitions at a given intensity, accumulate more training volume per session, and progress through rehabilitation protocols faster. For a patient working through a 12-week physical therapy program, the ability to do 2–3 additional repetitions per set translates into meaningfully more total work over the rehabilitation period.
Santos et al. (2004) found that creatine supplementation enhanced lean mass recovery and strength gains during a rehabilitation training program in elderly patients following hip arthroplasty. The creatine group showed greater improvement in functional measures including timed up-and-go and stair climbing. This is a population where every increment of strength recovery translates to meaningful functional independence.
Dosing During Recovery
The dosing strategy for injury recovery differs from standard athletic supplementation in one key respect: timing relative to the injury event. Ideally, creatine supplementation begins before the immobilization period — loading intramuscular stores so they start at maximum when disuse begins. Johnston et al. (2009) used a 7-day loading phase (20 g/day) before immobilization, followed by 5 g/day during the immobilized period.
For planned surgeries (elective ACL reconstruction, scheduled joint replacement), a pre-surgical creatine loading protocol is feasible: 20 g/day in 4 divided doses for 5–7 days before surgery, then 5 g/day throughout the immobilization and rehabilitation periods. This strategy maximizes intramuscular creatine at the moment when atrophy begins.
For unplanned injuries (acute fractures, traumatic ligament tears), pre-loading is not possible. In this case, beginning creatine supplementation as soon after injury as practical — even during the immobilization period — still provides benefit. Op 't Eijnde et al. (2001) demonstrated benefits from creatine supplementation that began at the start of immobilization, without a pre-injury loading phase.
| Phase | Protocol | Duration | Rationale |
|---|---|---|---|
| Pre-surgical loading | 20 g/day (4 x 5 g) | 5–7 days before surgery | Maximize intramuscular stores |
| Immobilization | 5 g/day | Throughout immobilized period | Maintain stores, slow atrophy |
| Early rehabilitation | 5 g/day | First 4–8 weeks | Support training volume recovery |
| Full rehabilitation | 3–5 g/day | Until strength baseline restored | Standard maintenance |
Practical Protocol by Injury Type
ACL reconstruction / knee surgery: Pre-surgical loading if time permits. Continue 5 g/day through the brace/limited-mobility phase (typically 2–6 weeks). Maintain during physical therapy (typically 6–12 months). Focus on preserving quadriceps mass, which is the primary rehabilitation target. Combine with adequate protein intake (1.6–2.2 g/kg/day) for maximal effect.
Upper limb fracture or surgery: Begin creatine immediately if not possible to pre-load. Standard dose of 5 g/day during immobilization. Continue during progressive loading. Upper limb muscles atrophy faster than lower limb muscles during immobilization (Wall et al., 2014), so the window for creatine benefit may be proportionally larger.
Bed rest / prolonged hospitalization: Creatine at 5 g/day is appropriate during extended bed rest, provided kidney function is adequate (check with medical team). Dirks et al. (2014) showed that protein supplementation preserves muscle during bed rest; creatine provides an additive mechanism through energy buffer maintenance. Combine creatine with electrical muscle stimulation or resistance exercise if available.
Concussion / mild traumatic brain injury: While creatine has neuroprotective properties in animal models of TBI (Sullivan et al., 2000), no clinical protocol exists for creatine supplementation following concussion in humans. The theoretical rationale is present (brain creatine supports recovery from metabolic crisis), but clinical recommendations await human trial data. Existing studies have examined prophylactic use in contact sport athletes, not acute treatment.
References
- Wall BT, Dirks ML, Snijders T, Senden JM, Dolmans J, van Loon LJ. Substantial skeletal muscle loss occurs during only 5 days of disuse. Acta Physiol (Oxf). 2014;210(3):600-611. PMID: 24168489.
- MacDougall JD, Ward GR, Sale DG, Sutton JR. Biochemical adaptation of human skeletal muscle to heavy resistance training and immobilization. J Appl Physiol. 1977;43(4):700-703. PMID: 908685.
- Johnston AP, Burke DG, MacNeil LG, Candow DG. Effect of creatine supplementation during cast-induced immobilization on the preservation of muscle mass, strength, and endurance. J Strength Cond Res. 2009;23(1):116-120. PMID: 19077740.
- Op 't Eijnde B, Urso B, Richter EA, Greenhaff PL, Hespel P. Effect of oral creatine supplementation on human muscle GLUT4 protein content after immobilization. Diabetes. 2001;50(1):18-23. PMID: 11147785.
- Hespel P, Op 't Eijnde B, Van Leemputte M, et al. Oral creatine supplementation facilitates the rehabilitation of disuse atrophy and alters the expression of muscle myogenic factors in humans. J Physiol. 2001;536(2):625-633. PMID: 11600695.
- Cooke MB, Rybalka E, Williams AD, Cribb PJ, Hayes A. Creatine supplementation enhances muscle force recovery after eccentrically-induced muscle damage in healthy individuals. J Int Soc Sports Nutr. 2009;6:13. PMID: 19500360.
- Gerber I, ap Gwynn I, Alini M, Wallimann T. Stimulatory effects of creatine on metabolic activity, differentiation and mineralization of primary osteoblast-like cells in monolayer and micromass cell cultures. Eur Cell Mater. 2005;10:8-22. PMID: 16025254.
- Chilibeck PD, Candow DG, Landeryou T, Kaviani M, Paus-Jenssen L. Effects of creatine and resistance training on bone health in postmenopausal women. Med Sci Sports Exerc. 2015;47(8):1587-1595. PMID: 25386713.
- Sullivan PG, Geiger JD, Mattson MP, Scheff SW. Dietary supplement creatine protects against traumatic brain injury. Ann Neurol. 2000;48(5):723-729. PMID: 11079535.
- Dirks ML, Wall BT, Nilwik R, Weerts DH, Verdijk LB, van Loon LJ. Skeletal muscle disuse atrophy is not attenuated by dietary protein supplementation in healthy older men. J Nutr. 2014;144(8):1196-1203. PMID: 24919690.